ONCOSEC MEDICAL INCORPORATED: 10-Q filed 2020-06-15
What ONCOSEC MEDICAL INCORPORATED reported in its quarterly report filed 2020-06-15 (fiscal Q3 2020): 36 published measures, 89 facts as tagged in accession 0001493152-20-011123.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2020-06-15
- Fiscal period
- fiscal Q3 2020
- Accession
- 0001493152-20-011123 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ONCOSEC MEDICAL INCORPORATED filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | 39,139,410 | USD | |
| At 2019-07-31 | 29,892,012 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | 17,435,552 | USD | |
| At 2019-07-31 | 5,612,913 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | 21,703,858 | USD | |
| At 2020-01-31 | 3,174,931 | USD | |
| At 2019-07-31 | 24,279,099 | USD | |
| At 2019-04-30 | 21,176,994 | USD | |
| At 2019-01-31 | 24,669,082 | USD | |
| At 2018-07-31 | 22,924,206 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | 30,078,144 | USD | |
| At 2019-07-31 | 25,147,780 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-02-01 to 2020-04-30 | -9,888,181 | USD | 90 |
| 2019-08-01 to 2020-04-30 | -33,282,689 | USD | 274 |
| 2019-02-01 to 2019-04-30 | -6,883,101 | USD | 89 |
| 2018-08-01 to 2019-04-30 | -22,773,744 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-04-30 | -23,783,320 | USD | 274 |
| 2018-08-01 to 2019-04-30 | -20,911,241 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-04-30 | 9,882 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-04-30 | 28,766,319 | USD | 274 |
| 2018-08-01 to 2019-04-30 | 17,194,767 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-04-30 | 22,203,912 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | -197,639,563 | USD | |
| At 2019-07-31 | -164,356,874 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-04-30 | 2,450 | USD | 274 |
| 2019-02-01 to 2019-04-30 | 3,520 | USD | 89 |
| 2018-08-01 to 2019-04-30 | 10,860 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | 865,211 | USD | |
| At 2019-07-31 | 1,031,129 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-04-30 | 2,213,176 | USD | 274 |
| 2018-08-01 to 2019-04-30 | 2,988,349 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-02-01 to 2020-04-30 | -9,834,680 | USD | 90 |
| 2019-08-01 to 2020-04-30 | -33,204,178 | USD | 274 |
| 2019-02-01 to 2019-04-30 | -6,913,989 | USD | 89 |
| 2018-08-01 to 2019-04-30 | -22,897,461 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | 31,815,353 | USD | |
| At 2019-07-31 | 28,507,336 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-04-30 | 1,070 | USD | 274 |
| 2019-02-01 to 2019-04-30 | 987 | USD | 89 |
| 2018-08-01 to 2019-04-30 | 987 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | 10,695,815 | USD | |
| At 2019-07-31 | 4,977,000 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-02-01 to 2020-04-30 | 6,103,163 | USD | 90 |
| 2019-08-01 to 2020-04-30 | 17,586,220 | USD | 274 |
| 2019-02-01 to 2019-04-30 | 4,222,193 | USD | 89 |
| 2018-08-01 to 2019-04-30 | 13,708,168 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | 22,771,571 | shares | |
| At 2019-07-31 | 10,633,043 | shares | |
| At 2019-05-20 | 7,121,594 | shares | |
| At 2019-05-19 | 71,216,082 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | 330,792 | USD | |
| At 2019-07-31 | 169,037 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | 6,156,939 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | 6,575,066 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | 1,991,000 | USD | |
| At 2019-07-31 | 1,991,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | 1,125,789 | USD | |
| At 2019-07-31 | 959,871 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | 301,907 | USD | |
| At 2019-07-31 | 353,547 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 635,913 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | 866,209 | USD | |
| At 2019-07-31 | 676,223 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-04-30 | 1,737,209 | USD | |
| At 2019-07-31 | 3,359,556 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-02-01 to 2020-04-30 | -9,888,181 | USD | 90 |
| 2019-08-01 to 2020-04-30 | -33,280,239 | USD | 274 |
| 2019-02-01 to 2019-04-30 | -6,879,581 | USD | 89 |
| 2018-08-01 to 2019-04-30 | -22,762,884 | USD | 273 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-02-01 to 2020-04-30 | -9,808,910 | USD | 90 |
| 2019-08-01 to 2020-04-30 | -33,120,934 | USD | 274 |
| 2019-02-01 to 2019-04-30 | -6,820,284 | USD | 89 |
| 2018-08-01 to 2019-04-30 | -22,649,069 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-02-01 to 2020-04-30 | 3,731,517 | USD | 90 |
| 2019-08-01 to 2020-04-30 | 15,617,958 | USD | 274 |
| 2019-02-01 to 2019-04-30 | 2,691,796 | USD | 89 |
| 2018-08-01 to 2019-04-30 | 9,189,293 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-04-30 | 165,918 | USD | 274 |
| 2018-08-01 to 2019-04-30 | 183,435 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-02-01 to 2020-04-30 | 54,908 | USD | 90 |
| 2019-08-01 to 2020-04-30 | 182,019 | USD | 274 |
| 2019-02-01 to 2019-04-30 | 113,360 | USD | 89 |
| 2018-08-01 to 2019-04-30 | 333,665 | USD | 273 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-04-30 | 1,624 | USD | 274 |
| 2018-08-01 to 2019-04-30 | 987 | USD | 273 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2020-04-30 | 2,450 | USD | 274 |
| 2018-08-01 to 2019-04-30 | 1,700 | USD | 273 |
Operating lease payments
Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-02-01 to 2020-04-30 | 360,706 | USD | 90 |
| 2019-08-01 to 2020-04-30 | 1,043,192 | USD | 274 |
Inspect the source
- Entity
- ONCOSEC MEDICAL INCORPORATED / CIK 0001444307
- Captured
- SEC response SHA-256
326bcab6a98b5e6098a865fe967c999ac8b3247d9466d112c5306da6df2f5607
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001444307.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))